Company / Operating Margin
Amneal Pharmaceuticals, Inc. Operating Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
13.1%
FY2025
5-year range
-15.3% / 13.1%
FY2021-FY2025
Trend
+46.3%
vs FY2024
Sector context
#35 of 136
Health Care
What the data says
At 13.1%, Amneal Pharmaceuticals, Inc.'s operating margin ranks #35 of 136 in the Health Care sector. Operating Margin has increased for 4 consecutive years, from -15.3% in FY2021 to 13.1% in FY2025.
Based on SEC 10-K filings.
13.1% in FY2025 with a 5-year CAGR of +14.2%.
Improved from 7.3% to 13.1% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- +17.3pp
- 5-Year Change
- +14.2pp
- 10-Year Change
- -
Sector benchmark
#35 of 136 in Health CareTop 26% of 136This company 13.1% Sector average -778.9%
▼
+101.7% above sector average
Key checks
Key Insights
- Amneal Pharmaceuticals, Inc.'s operating margin has grown for 4 consecutive years.
- In FY2025, operating margin increased 46.3% year-over-year.
- Currently 792.0pp above the Health Care sector average.
- Peak operating margin was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 13.1% | +46.3% |
| FY2024 | 8.9% | +22.4% |
| FY2023 | 7.3% | +269.9% |
| FY2022 | -4.3% | +71.9% |
| FY2021 | -15.3% | -1195.8% |
| FY2020 | -1.2% | -105.0% |
| FY2019 | 23.7% | -15.3% |
| FY2018 | 28.0% | +18.0% |
| FY2017 | 23.7% | -15.3% |
| FY2016 | 28.0% | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026